Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas
Gary Kohanbash(University of Pittsburgh), Hideho Okada(University of California, San Francisco)
Cited by 411
Related Papers
Induction of CD8<sup>+</sup>T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
|Journal of Clinical Oncology|2010|561
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
|The Journal of Experimental Medicine|2017|215
Inhibition of STAT3 Promotes the Efficacy of Adoptive Transfer Therapy Using Type-1 CTLs by Modulation of the Immunological Microenvironment in a Murine Intracranial Glioma
|The Journal of Immunology|2008|104
Blockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy
|Cell Death and Disease|2018|61